|
|
|
|
|
|
|
||
© The Rockefeller University Press,
0021-9525/2000//283 $5.00
The Journal of Cell Biology, Volume 148, Number 2,
, 2000 283-292
Original Article |
Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
bazett{at}ucalgary.ca
The promyelocytic leukemia (PML) nuclear body (also referred to as ND10, POD, and Kr body) is involved in oncogenesis and viral infection. This subnuclear domain has been reported to be rich in RNA and a site of nascent RNA synthesis, implicating its direct involvement in the regulation of gene expression. We used an analytical transmission electron microscopic method to determine the structure and composition of PML nuclear bodies and the surrounding nucleoplasm. Electron spectroscopic imaging (ESI) demonstrates that the core of the PML nuclear body is a dense, protein-based structure, 250 nm in diameter, which does not contain detectable nucleic acid. Although PML nuclear bodies contain neither chromatin nor nascent RNA, newly synthesized RNA is associated with the periphery of the PML nuclear body, and is found within the chromatin-depleted region of the nucleoplasm immediately surrounding the core of the PML nuclear body. We further show that the RNA does not accumulate in the protein core of the structure. Our results dismiss the hypothesis that the PML nuclear body is a site of transcription, but support the model in which the PML nuclear body may contribute to the formation of a favorable nuclear environment for the expression of specific genes.
Key Words: transcription • nuclear structure • acetylated chromatin • correlative microscopy • electron spectroscopic imaging
© 2000 The Rockefeller University Press
 |
Introduction |
|---|
 TopAbstract Introduction Materials and MethodsResultsDiscussionReferences |
|---|
PML nuclear bodies are also a target of a variety of viruses, and are thought to be involved in coordinating the expression and replication of viral genomes from phylogenetically distinct families (for a review, see Sternsdorf et al. 1997a). A number of DNA viruses, such as SV40, Ad5, and HSV-1, begin replication in the vicinity of a few, but not all, of the PML bodies in a nucleus. Increased amounts of infectious virus in a cell do not result in an increase in the number of nuclear sites of viral replication. This implies that PML nuclear bodies may not be identical ( De Bruyn-Kops and Knipe 1994; Maul 1998). Viral protein expression does not appear to be necessary for targeting viral genomes to these replication sites ( Ishov and Maul 1996). Transcription of the viral genome also takes place at the periphery of the PML nuclear bodies, perhaps because they create a suitable environment ( Ishov et al. 1997; Maul 1998). Finally, many viruses disassemble or degrade PML nuclear bodies before proceeding to the late phase in infection cycles ( Doucas et al. 1996; Maul et al. 1996; Ishov et al. 1997; Maul 1998). This may have a disruptive effect on host nuclear function.
The cellular role of the PML nuclear body remains uncertain, despite its obvious links to oncogenesis and viral infection (for reviews, see Sternsdorf et al. 1997a; Slack and Gallagher 1999). PML nuclear bodies may be sites of storage of transcription factors, sites of transcription, or sites of RNA accumulation. The presence of RNA, by fluorescein-UTP microinjection and EDTA-regressive staining, has been observed within the structure of the PML nuclear body ( LaMorte et al. 1998), indicating a potential role in the transcription of some genes. The high enrichment of the transcriptional coactivator/histone acetyltransferase, CBP, is further suggestive of transcriptional activity within this domain ( LaMorte et al. 1998; Doucas et al. 1999). Consequently, it is important to understand the composition of these structures and the composition and organization of the surrounding nucleoplasm. In this study, we used both indirect immunofluorescence microscopy and a novel analytical transmission electron microscope method, electron spectroscopic imaging (ESI), to address the composition of PML nuclear bodies. PML nuclear bodies did not stain with antibodies recognizing highly acetylated histones nor those recognizing fluorine-substituted uridine (FU). Furthermore, phosphorus mapping by ESI rules out the presence of chromatin or RNA within these structures. However, nascent RNA can be detected at the periphery, indicating that the surroundings of the PML nuclear bodies are sites of transcriptional activity.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Correlative Microscopy and Electron Microscopy
Detailed descriptions of the EM procedure are presented elsewhere ( Bazett-Jones and Hendzel 1999). In brief, cells were grown on polypropylene caps, fixed with 1.0% paraformaldehyde in PBS, and labeled for immunofluorescence as described above. Cells were then refixed in 2% glutaraldehyde in PBS for 5 min, dehydrated in ethanol, starting at 30%, before embedding in Quetol 651 resin. We have found that this fixation procedure preserves fine structural detail in chromatin. Moreover, chromatin-based and protein-based fibers are routinely observed ( Bazett-Jones and Hendzel 1999; Bazett-Jones et al. 1999; Hendzel et al. 1999). To reveal the detail seen with this protocol, a section from the same block as that used for data in this paper was stained with uranyl acetate and imaged in bright-field ( Fig. 1A and Fig. B). Elastic images recorded at 0-eV energy loss reveal well preserved heterochromatin masses along the nuclear envelope. Fine structural detail is particularly evident in the high magnification, uranium-enhanced image (recorded at 120 eV) of the region indicated in Fig. 1 C.
|
30- and 90-nm thickness were obtained by ultramicrotomy with a diamond knife (Drukker), and were picked up onto finder grids. These lettered grids allow particular cells in the section, first imaged in the fluorescent microscope, to easily be found later in the electron microscope. Electron micrographs were obtained with a Gatan 14-bit slow scan cooled CCD detector on a Zeiss EM 902 transmission electron microscope equipped with an imaging spectrometer ( Bazett-Jones and Hendzel 1999). All images were corrected by dark current subtraction before being used for analysis. Energy filtered images recorded before an inner shell ionization edge do not contain element-specific information, but serve as a reference for the element-enhanced image recorded at an energy loss on, or just beyond, the inner shell ionization edge. In the case of phosphorus imaging, for example, an image recorded at an energy loss of 120 eV serves as a reference for the phosphorus-enhanced image recorded at 155 eV. A phosphorus map can be formed by subtracting the 120-eV image from the 155-eV image, after alignment to within a pixel, and normalization of the two images on a region that is known not to contain phosphorus; or, by dividing the 155-eV image by the 120-eV image after alignment of the two images. Similarly, a reference image for nitrogen is recorded at 385 eV and the nitrogen-enhanced image is recorded at an energy loss of 415 eV ( Bazett-Jones and Hendzel 1999). The sections are preirradiated before the images are recorded. Preirradiation stabilizes the section and produces a state of terminal mass loss. Therefore, no mass loss occurs during the recording of the complete set of reference and element-enhanced images. All images are recorded with nearly equal exposures measured over the background resin to insure equal signal counting statistics at the detector level for all images ( Bazett-Jones and Hendzel 1999; Bazett-Jones et al. 1999). Examples of reference, element-enhanced, and element maps for phosphorus and nitrogen are shown in Fig. 1D-I. Blocks of chromatin on the nuclear envelope (top of image in Fig. 1, D–I), throughout the nucleoplasm, and at the surface of the nucleolus ( Fig. 2, Nu), are clearly seen in the phosphorus map. The granular component of the nucleolus has less contrast than the blocks of chromatin, but more contrast than the nucleoplasm or the cytoplasm. Blocks of chromatin can also be seen in nitrogen maps, but distinguishing chromatin from the granular component of the nucleolus, for example, is more difficult because nitrogen is present in both protein and nucleic acid. The granular component of the nucleolus has a higher protein/nucleic acid ratio than that of chromatin.
|
A 600-µm condenser aperture and a 90-µm objective aperture were used. The energy-selecting slit aperture was set to correspond to 20 eV. To measure the relative amount of phosphorus or nitrogen in various morphologically defined structures in and around PML nuclear bodies, we used the technique called image EELS (electron energy-loss spectroscopy). Images of a selected field are collected at small steps (e.g., 10 eV) in the energy-loss spectrum, spanning, for example, the phosphorus L2,3 and nitrogen K edges. Masks are used to delineate objects of interest, and the mean signals under these masks are measured in every image. If a structure contains phosphorus, a steep increase in the energy-loss spectrum above 132 eV will emerge, along with a second steep increase beyond 150 eV, due to the delayed characteristic of this energy-loss event. The presence of nitrogen is more obvious than phosphorus, due to a sharper, less delayed event beginning at 385 eV (see Bazett-Jones et al. 1999). Measurements of signal intensities in the masked regions were made with ErgoVista 4.4 image analysis software.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Positive identification of PML nuclear bodies amongst other nuclear structures with ESI alone is difficult. To identify these structures definitively, we first labeled cells with antibodies against the NH2 terminus of CBP, which we have shown to colocalize with PML in PML nuclear bodies in SK-N cells, by immunofluorescence microscopy. Indeed, in this cell line, CBP is as reliable a marker of PML nuclear bodies as for the PML protein itself. After embedding and thin sectioning, the same section can first be examined in the fluorescence microscope to identify the location of PML nuclear bodies in individual cells. The same section is then imaged at high resolution in the energy-filtering electron microscope ( Bazett-Jones et al. 1999). A thin section showing a nucleus imaged by immunofluorescence is shown in Fig. 2 A. Five PML nuclear bodies can easily be identified. Two are indicated ( Fig. 2A, Fig. D, and Fig. E, arrows) near the nucleolus ( Fig. 2 A, D, and E, Nu). The same section imaged at 155-eV energy loss is shown in Fig. 2 B at low magnification and superimposed with the immunofluorescence image in Fig. 2 C, to correlate the fluorescently labeled structures with the underlying ultrastructure. Two PML nuclear bodies are then detectable in the high magnification phosphorus ( Fig. 2 D) and nitrogen ( Fig. 2 E) maps. The cores of each of these nuclear bodies are well contrasted in the nitrogen map, whereas the phosphorus content is low. Notably, there is no evidence of small fibers or granules rich in phosphorus. Such signals are always observed when RNA or DNA is present, even as structures in the 2–10 nm range. These results indicate that the cores are mainly composed of protein.
The Core of the PML Nuclear Body Is a Protein-based Structure
Qualitative analysis of such images ( Fig. 2D and Fig. E) indicates that the core of the PML nuclear body is depleted in nucleic acids. Fig. 3 shows high magnification images of a PML nuclear body ( Fig. 3, left, phosphorous map, right, nitrogen map). The presence of RNA or DNA in this structure would likely resemble phosphorus-rich granules, as seen in the core of the interchromatin granule clusters and throughout the nucleoplasm ( Hendzel et al. 1998, Hendzel et al. 1999), or more extended fibrils, reflecting noncompacted nucleic acids ( Hendzel et al. 1999). Such structures are not apparent, even at high magnification ( Fig. 3). To extend the morphological analysis, we quantified the phosphorus and nitrogen content in different regions around the PML nuclear body ( Fig. 3B and Fig. D). The core of the PML nuclear body, a region corresponding to condensed chromatin, a background region in the nucleoplasm, and a background outside of the cell comprised of the embedding resin alone (not shown) were delineated with masks. The mean integrated signals from the energy-loss spectrum spanning the phosphorus L2,3 and nitrogen K edges were measured over the regions delineated by the masks ( Fig. 3B and Fig. D). No phosphorus or nitrogen can be detected in the embedding resin, indicated by the flat line in both spectra. The standard deviation in the phosphorus and nitrogen signal intensities was always <2% of the mean for the PML nuclear body, the chromatin, and the nucleoplasm. Error bars indicating these values would not show outside of the symbols on the graphs. The masks for the embedding resin, the chromatin, and the core of the PML nuclear body are approximately equal in area, whereas the mask for the nucleoplasm had to be smaller, 0.25 of the area of the others. However, the standard deviation of the means of numerous small regions of the nucleoplasm was also <0.5%, indicating that differences in sampling between nucleoplasm and nuclear structures do not account for the differences in element concentrations measured. The energy-loss spectra of regions in the nucleus are consistent with the presence of phosphorus, characterized by the strong delayed edge above 150 eV. The phosphorus content (155 eV) of the core of the PML nuclear body was 1.4% above the nucleoplasmic background, whereas the chromatin was 16% above the nucleoplasmic background, corresponding to a signal 11 times higher for the chromatin compared with the PML nuclear body. In contrast, the nitrogen signal (415 eV) for chromatin is 9% over the nucleoplasm and the PML body core is 10% over the nucleoplasmic background. The phosphorus signal in the nucleoplasmic background is likely derived predominantly from phosphorylated proteins. Because of a comparable phosphorus signal in the PML nuclear body core and the nucleoplasm, and the absence of morphologically recognizable phosphorus-rich complexes, we conclude that the core of this subnuclear structure does not contain nucleic acid (DNA and RNA) and is composed only of protein.
|
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
First, we have shown that the core of the PML nuclear body is composed entirely, or almost entirely, of protein. There is no detectable nucleic acid in the 250-nm-diam core of the structure. This core is not a uniform sphere of protein, but rather has channels and pores throughout. Serial sections ( Fig. 4) indicate that the mass density of the very center is much lower than the outer regions of the core. Many proteins have been shown to localize to PML nuclear bodies, such as the transcription regulatory factor PML protein, the transcriptional coactivator CBP, and other proteins, such as Sp100. It is likely that such components of the PML nuclear body are localized in this core structure, and the core represents a specialized component of the karyoskeleton ( Hendzel et al. 1999).
The second major finding in this paper is that the protein-based core is surrounded by blocks of chromatin that are condensed to levels beyond the 30-nm fiber. In cross-sections, phosphorus maps illustrate a discontinuous ring of chromatin around the protein-based core, and by serial sectioning, phosphorus maps demonstrate that the blocks of chromatin completely surround the core. In future experiments, we will investigate whether some of this chromatin is participating in transcriptional activity.
The third major finding relates to the PML body as a site for RNA synthesis. Both ESI and long incubation times in the presence of fluorescently detected label reveal that the core of the structure always remains free of RNA. Nevertheless, phosphorus-rich fibers that are morphologically more consistent with RNA than chromatin are observed in the space between the protein core and the blocks of chromatin. It remains to be shown whether the apparent association of highly acetylated chromatin, FU incorporation, and the RNA fibers reflect a functional relationship to the PML nuclear body or reflect a random association. It might be expected that the high levels of CBP, located in PML nuclear bodies, would contribute to a favorable environment for chromatin remodeling and transcriptional activity. The presence of nascent RNA at the periphery of this structure is concordant with the observation by Ishov et al. 1997, who localized viral transcripts next to this nuclear body.
Our conclusions differ dramatically from those of LaMorte and coworkers ( LaMorte et al. 1998). These authors used EDTA-regressive staining technique, which preferentially labels RNA ( Bernhard 1969), and fluorescein-UTP incorporation in situ nuclear run-on experiments to conclude that very high concentrations of RNA are localized within the structure. Both experiments have limitations. The specificity of the EDTA-regressive staining procedure is not absolute, and, in the case of structures of unknown composition, cannot be interpreted to be RNA-based solely on the presence of staining after the EDTA chelation of uranium ions from chromatin ( Bernhard 1969). We report here that the core of the PML nuclear body contains only nucleoplasmic background levels of phosphorus and no discernible phosphorus-rich fibers. This holds for all PML nuclear bodies observed and does not characterize a small subset of these structures ( LaMorte et al. 1998). As a positive control for our observation that the core contains little or no RNA, subnuclear domains that are known to contain high amounts of RNA do have high phosphorus signals when imaged by ESI. These structures include 30-nm chromatin fibers, the nucleolus ( Fig. 2 D), interchromatin granule clusters ( Hendzel et al. 1998), or the Sam 68 nuclear bodies ( Chen et al. 1999). Because the sensitivity of these procedures has been shown to be very high ( Bazett-Jones and Hendzel 1999; Bazett-Jones et al. 1999; Hendzel et al. 1999), our results rule out the possibility that the intense staining of these structures using the EDTA-regressive staining method is the result of an abundance of RNA within the structure. Similarly, the nuclear run-on experiment, which shows labeling of the PML nuclear bodies, has a greater potential for experimental artifacts than does the direct incorporation into RNA through addition of FU into the tissue culture medium.
We present a number of independent methods that demonstrate an absence of: bulk chromatin; acetylated chromatin; newly synthesized RNA; or phosphorus-rich nucleic acids; in the core of the PML nuclear body. Therefore, we conclude that it is highly unlikely that the PML nuclear body represents a higher-order nuclear structure that nucleates or aggregates around specific clusters of transcriptionally active genes or even single, highly active genes. Instead, the presence of transcription regulatory factors within the PML nuclear body and the blocks of chromatin and nascent RNA in the immediate vicinity of the PML nuclear body, raise the importance of further experimentation to test whether these structures are responsible for creating or establishing a transcriptional domain. A nuclear-neighbor hypothesis for regulation of nuclear events has been presented to explain a number of similar relationships involving subnuclear domains ( Schul et al. 1998).
Subnuclear compartments that function to concentrate regulatory factors and complexes may be important in modulating gene expression ( Schul et al. 1998). The interchromatin granule cluster (IGC), for example, is able to concentrate transcriptional coactivators in the protein-rich core, and is surrounded by transcriptionally active chromatin ( Hendzel et al. 1998). Indeed, the peripheries of IGCs are sites of transcription of particular genes ( Smith et al. 1999). PML nuclear bodies, which, incidentally, are generally associated with IGCs ( Ishov et al. 1997), may also serve to concentrate regulatory factors that service transcriptional events on their surfaces. Genes that are implicated in requiring PML nuclear bodies for expression are early viral genes ( Guldner et al. 1992; Chelbi-Alix et al. 1995; Lavau et al. 1995; Grotzinger et al. 1996; Ishov et al. 1997) and, possibly, genes important for immune function, including MHC class I and II ( Kretsovali et al. 1998; Zheng et al. 1998; Fontes et al. 1999).
|
Acknowledgments |
|---|
This work was funded by operating grants from the Cancer Research Society, Inc., and the Medical Research Council of Canada. The Microscopy and Imaging Facility, University of Calgary, is supported by a maintenance grant from the Medical Research Council of Canada.
Submitted: 8 July 1999
Revised: 1 December 1999
Accepted: 8 December 1999
Michael J. Hendzel's current address is Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada T6G 1Z2.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Ascoli C.A. & Maul G.G.. Identification of a novel nuclear domain, J. Cell Biol., 112, 1991, 785–795 .
Bazett-Jones D.P. & Hendzel M.J.. Electron spectroscopic imaging of chromatin, Companion Meth. Enzymol, 17, 1999, 188–200.
Bazett-Jones D.P., Hendzel M.J. & Kruhlak M.J.. Stoichiometric analysis of protein- and nucleic acid-based structures in the cell nucleus, Micron, 30, 1999, 151–157 .[Medline]
Bernhard W.. A new staining procedure for electron microscopical cytology, J. Ultrastruct. Res., 27, 1969, 250–265 .[Medline]
Boggs B.A., Connors B., Sobel R.E., Chinaud A.C. & Allis C.D.. Reduced levels of histone H3 acetylation on the inactive X chromosomes as shown by histone acetylation, Chromosoma, 105, 1996, 41–49 .[Medline]
Borrow J., Goddard A.D., Sheer D. & Solomon E.. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17, Science., 249, 1990, 1577–1580 .
Chang K.S., Fan Y.-H., Andreeff M., Liu J. & Mu Z.-M.. The PML gene encodes a phosphoprotein associated with the nuclear matrix, Blood, 85, 1995, 3646–3653 .
Chelbi-Alix M.K., Pelicano L., Quignon F., Koken M.H.M., Venturini L., Stadler M., Pavlovic J., Degos L. & de The H.. Induction of the PML protein by interferons in normal and APL cells, Leukemia., 9, 1995, 2027–2033 .[Medline]
Chen T., Boisvert F.-M., Bazett-Jones D.P. & Richard S.. A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines, Mol. Biol. Cell., 10, 1999, 3015–3033 .
De Bruyn-Kops A. & Knipe D.M.. Preexisting nuclear architecture defines the intranuclear location of herpes virus DNA replication structures, J. Virol, 68, 1994, 3512–3526 .
De Graaf A., Humbel B.M., Stuurman N., van Bergen en Henegouwen P.M.P. & Verkleij A.J.. Three-dimensional immunogold labeling of nuclear matrix proteins in permeabilized cells, Cell Biol. Int. Rep, 16, 1992, 827–836 .[Medline]
de The H., Chomienne C., Lanotte M., Degos L. & Dejean A.. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus, Nature., 347, 1990, 558–561 .[Medline]
de The H., Lavau C., Marchio A., Chomienne C., Degos L. & Dejean A.. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR, Cell., 66, 1991, 675–684 .[Medline]
Desbois C., Rousset R., Bantignies F. & Jalinot P.. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I tax oncoprotein, Science, 273, 1996, 951–953 .[Abstract]
Doucas V., Ishov A.M., Romo A., Juguilon H., Weitzman M.D., Evans R.M. & Maul G.G.. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure, Genes Dev, 10, 1996, 196–207 .
Doucas V., Tini M., Egan D.A. & Evans R.M.. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling, Proc. Natl. Acad. Sci. USA., 96, 1999, 2627–2632 .
Duprez E., Saurin A.J., Desterro J.M., Lallemand-Breitenbach V., Howe K., Boddy M.N., Solomon E., de The H., Hay R.T. & Freemont P.S.. SUMO-1 modification of the acute promyelocytic leukaemia protein PMLimplications for nuclear localisation, J. Cell Sci., 112, 1999, 381–393 .[Abstract]
Dyck J.A., Maul G.G., Miller W.H. Jr., Chen J.D., Kakizuka A. & Evans R.M.. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein, Cell., 76, 1994, 333–343 .[Medline]
Fagioli M., Alcalay M., Tomassoni L., Ferrucci P.F., Mencarelli A., Riganelli D., Grignani F., Pozzan T., Nicoletti I., Grignani F. & Pelicci P.G.. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival, Oncogene., 16, 1998, 2905–2913 .[Medline]
Fontes J.D., Kanazawa S., Jean D. & Peterlin B.M.. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes, Mol. Cell. Biol, 19, 1999, 941–947 .
Grande M.A., van der Kraan I., van Steensel B., Schul W., de The H., van der Voort H.T.M., de Jong L. & van Driel R.. PML-containing nuclear bodiestheir spatial distribution in relation to other nuclear components, J. Cell. Biochem., 63, 1996, 280–291 .[Medline]
Grotzinger T., Sternsdorf T., Jensen K. & Will H.. Interferon-modulated expression of genes encoding the nuclear-dot–associated proteins Sp100 and promyelocytic leukemia protein (PML), Eur. J. Biochem, 238, 1996, 554–560 .[Medline]
Guldner H.H., Szostecki C., Grotzinger T. & Will H.. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis, J. Immunol, 149, 1992, 4067–4073 .[Abstract]
Hendzel M.J., Kruhlak M.J. & Bazett-Jones D.P.. Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation, Mol. Biol. Cell, 9, 1998, 2491–2507 .
Hendzel M.J., Boisvert F.-M. & Bazett-Jones D.P.. Direct visualization of a protein nuclear architecture, Mol. Biol. Cell, 10, 1999, 2051–2062 .
Ishov A.M. & Maul G.G.. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition, J. Cell Biol., 134, 1996, 815–826 .
Ishov A.M., Stenberg R.M. & Maul G.G.. Human cytomegalovirus immediate early interaction with host nuclear structuresdefinition of an immediate transcript environment, J. Cell Biol, 138, 1997, 5–16 .
Kakizuka A., Miller W.H. Jr., Umesono K., Warrell R.P. Jr., Frankel S.R., Murty V.V., Dmitrovsky E. & Evans R.M.. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML, Cell, 66, 1991, 663–674 .[Medline]
Koken M.H.M., Puvion-Dutilleul F., Guillemin M.C., Viron A., Linares-Cruz G., Stuurman N., de Jong L., Szostecki C., Calvo F. & Chomienne C.. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion, EMBO (Eur. Mol. Biol. Organ.) J., 13, 1994, 1073–1083.[Medline]
Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M. & Papamatheakis J.. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator, Mol. Cell. Biol, 18, 1998, 6777–6783 .
LaMorte V.J., Dyck J.A., Ochs R.L. & Evans R.M.. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body, Proc. Natl. Acad. Sci. USA., 95, 1998, 4991–4996 .
Lavau C., Marchio A., Fagioli M., Jansen J., Falini B., Lebon P., Grosveld F., Pandolfi P.P., Pelicci P.G. & Dejean A.. The acute promyelocytic leukaemia-associated PML gene is induced by interferon, Oncogene, 11, 1995, 871–876 .[Medline]
Le X.F., Yang P. & Chang K.S.. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML, J. Biol. Chem, 271, 1996, 130–135 .
Malatesta M., Zancanaro C., Martin T.E., Chan E.K., Amalric F., Luhrmann R., Vogel P. & Fakan S.. Is the coiled body involved in nucleolar functions?, Exp. Cell Res., 211, 1994, 415–419 .[Medline]
Maul G.G.. Nuclear domain 10, the site of DNA virus transcription and replication, BioEssays., 20, 1998, 660–667 .[Medline]
Maul G.G., Ishov A.M. & Everett R.D.. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1, Virology., 217, 1996, 67–75 .[Medline]
Muller S., Matunis M.J. & Dejean A.. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus, EMBO (Eur. Mol. Biol. Organ.) J., 17, 1998, 61–70.[Medline]
Schul W., de Jong L. & van Driel R.. Nuclear neighboursthe spatial and functional organization of genes and nuclear domains, J. Cell Biochem., 70, 1998, 159–171 .[Medline]
Slack J.L. & Gallagher R.E.. The molecular biology of acute promyelocytic leukemia, Cancer Treat. Res., 99, 1999, 75–124 .[Medline]
Smith K.P., Moen P.T., Wydner K.L., Coleman J.R. & Lawrence J.B.. Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific, J. Cell Biol., 144, 1999, 617–629 .
Sternsdorf T., Grotzinger T., Jensen K. & Will H.. Nuclear dotsactors on many stages, Immunobiol., 198, 1997, 307–331a.[Medline]
Sternsdorf T., Jensen K. & Will H.. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1, J. Cell Biol, 139, 1997, 1621–1634b .
Sternsdorf T., Jensen K., Reich B. & Will H.. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers, J. Biol. Chem, 274, 1999, 12555–12566 .
Stuurman N., de Graaf A., Floore A., Josso A., Humbel B., de Jong L. & van Driel R.. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies, J. Cell Sci., 101, 1992, 773–784 .
Szostecki C., Guldner H.H., Netter H.J. & Will H.. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis, J. Immunol, 145, 1990, 4338–4347 .[Abstract]
Vallian S., Gaken J.A., Trayner I.D., Gingold E.B., Kouzarides T., Chang K.S. & Farzaneh F.. Transcriptional repression by the promyelocytic leukemia protein, PML, Exp. Cell. Res., 237, 1997, 371–382 .[Medline]
Vallian S., Chin K.V. & Chang K.S.. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter, Mol. Cell. Biol, 18, 1998, 7147–7156a .
Vallian S., Gaken J.A., Gingold E.B., Kouzarides T., Chang K.S. & Farzaneh F.. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein, Oncogene., 16, 1998, 2843–2853b .[Medline]
Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R. & Pandolfi P.P.. PML is essential for multiple apoptotic pathways, Nat. Genet, 20, 1998, 266–272 .[Medline]
Xie K., Lambie E.J. & Snyder M.. Nuclear dot antigens may specify transcriptional domains in the nucleus, Mol. Cell. Biol, 13, 1993, 6170–6179 .
Zheng P., Guo Y., Niu Q., Levy D.E., Dyck J.A., Lu S., Sheiman L.A. & Liu Y.. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation, Nature, 396, 1998, 373–376.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
